Welcome to issue 12 of the Dividend Talk newsletter!
It feels like so much has happened since last we published a newsletter. Regarding dividend hikes, we have had large increases like Assa Abloy or mediocre increases like British American Tobacco, but not much in between. Of course, there are always outliers, and Bayer and Enagas come in with big dividend cuts, which affect both EDGI’s and Dereks’s portfolios. We focus more on Enagas in this Newsletter because Derek bought more shares in January, so he has a big decision to make.
If you are new to this newsletter and would like to give it a try, then check out the first 3 newsletters for free:
1. A deep dive into LβOreal | Newsletter #001
2. A deep dive into British American Tobacco | Newsletter #002
3. A deep dive into NN Group β is their Dividend Safe? | Newsletter #003
What you can expect in this issue:
- A deep dive into Legal & General. Is this high-yielding UK stock worth the risk?
- A mini dive into a company in the semiconductor industry called Melexis.
- Does China pose a risk for Texas Instruments?
- New Stock cards such as Snap-On
- Our watchlist and most recent transactions.
- Three financial statements course.
Feel free to reach out to us until Wednesday with your suggestion for the next deep dive.
Yours Truly,
European Dividend Growth Investor & Derek from Dividend Talk.
Premium subscribers can download the newsletter below (after login) π
<< Download Newsletter by Clicking here >>>